Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Effects of Speech-therapy in Hypertensive Patients [NA]
A clinical trial evaluating the effects of speech therapy on blood pressure in hypertensive patients has completed.
-
FDA approval · 2016-02-11FDA Approved: QUINAPRIL HCL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for a quinapril hydrochloride and hydrochlorothiazide fixed-dose combination ge…
-
FDA approval · 2016-02-11FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) from Cosette Pharmaceuticals, Inc. Th…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Improving Hypertension Control in the Inner City
A completed clinical trial aimed at improving hypertension control in inner-city patients.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Proarrhythmic Medicines and Primary Cardiac Arrest
A completed clinical trial investigating whether proarrhythmic medicines are associated with primary cardiac arrest.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Central Obesity and Disease Risk in Japanese Americans
This completed clinical trial investigated how central obesity relates to the risk of cardiovascular and metabolic diseases in Japanese Amer…
-
FDA approval · 2016-02-09FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental NDA for the fixed-dose combination candesartan cilexetil and hydrochlorothiazide manufactured by ANI Pharmaceuti…
-
FDA approval · 2016-02-08FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis Pharmaceuticals Corporat…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors [NA]
A completed clinical trial evaluating the effects of Xoçai antioxidant supplements on atherosclerosis risk factors in participants with hype…
-
CLINICAL_TRIALS research · 2016-02-08Clinical Trial Update: Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study
This entry notes a completed ancillary eye study for the Multi-Ethnic Study of Atherosclerosis (MESA), sponsored by the University of Wiscon…
-
CLINICAL_TRIALS research · 2016-02-08Clinical Trial Update: Validation of a Hypertension Education Program [NA]
An update on a clinical trial validating a hypertension education program.
-
FDA approval · 2016-02-08FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Solco Healthcare US, LLC)
FDA approved an original application for a generic fixed-dose combination of valsartan and hydrochlorothiazide by Solco Healthcare US, LLC.
-
FDA approval · 2016-02-05FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Avalide (irbesartan and hydrochlorothiazide) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2016-02-05FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for AVAPRO (irbesartan) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2016-02-05FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for a generic fixed-dose combination of amlodipine and valsartan by Strides Pharma Science Limited f…
-
CLINICAL_TRIALS research · 2016-02-05Clinical Trial Update: Minnesota Heart Survey - Risk Factor Survey
Clinical trial update for the Minnesota Heart Survey risk factor survey. It is an observational study focusing on cardiovascular risk factor…
-
CLINICAL_TRIALS research · 2016-02-04Clinical Trial Update: Renal Denervation for the Treatment of Hypertension: A Pilot Safety and Efficacy Study [NA]
This entry reports a pilot safety and efficacy study of renal denervation for hypertension, with the trial status currently listed as unknow…
-
FDA approval · 2016-02-02FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC.
-
CLINICAL_TRIALS research · 2016-02-02Clinical Trial Update: Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials
This article presents a meta-analysis of randomized controlled trials evaluating the effects of soluble fiber on blood pressure. It synthesi…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010) [Phase 1]
Phase 1 trial assessing co-administration of MK-4618 with antihypertensive agents in hypertension; completed with results posted in 2016.
-
FDA approval · 2016-01-28FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for amlodipine besylate from Cipla USA Inc.
-
CLINICAL_TRIALS research · 2016-01-27Clinical Trial Update: The Trinity, Ulster and Department of Agriculture Cohort Study
A clinical trial update for the Trinity, Ulster and Department of Agriculture Cohort Study led by the University of Ulster; the trial status…
-
FDA approval · 2016-01-26FDA Approved: NIFEDIPINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for nifedipine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. This action repres…
-
FDA approval · 2016-01-26FDA Approved: FOSINOPRIL SODIUM — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for fosinopril sodium (fosinopril) submitted by Cipla USA Inc., enabling continued marketing of …
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension [Phase 3]
A Phase 3 efficacy and safety trial of a valsartan-chlorthalidone conjugate for hypertension has completed, evaluating its performance again…